226 related articles for article (PubMed ID: 36854280)
21. Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model.
Liu B; Xiao Y; Li H; Zhang AL; Meng LB; Feng L; Zhao ZH; Ni XC; Fan B; Zhang XY; Zhao SB; Liu YB
Biomed Res Int; 2020; 2020():6954793. PubMed ID: 32626756
[TBL] [Abstract][Full Text] [Related]
22. Ceruloplasmin overexpression is associated with oncogenic pathways and poorer survival rates in clear-cell renal cell carcinoma.
Zhang Y; Chen Z; Chen JG; Chen XF; Gu DH; Liu ZM; Gao YD; Zheng B
FEBS Open Bio; 2021 Nov; 11(11):2988-3004. PubMed ID: 34449964
[TBL] [Abstract][Full Text] [Related]
23. Identification of
Yang H; Wang Y; Zhang Z; Li H
Front Genet; 2020; 11():905. PubMed ID: 32973873
[TBL] [Abstract][Full Text] [Related]
24. Identification of biomarkers related to CD8
Lin J; Yu M; Xu X; Wang Y; Xing H; An J; Yang J; Tang C; Sun D; Zhu Y
Aging (Albany NY); 2020 Feb; 12(4):3694-3712. PubMed ID: 32081834
[TBL] [Abstract][Full Text] [Related]
25. Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.
Chen YH; Chen SH; Hou J; Ke ZB; Wu YP; Lin TT; Wei Y; Xue XY; Zheng QS; Huang JB; Xu N
Aging (Albany NY); 2019 Oct; 11(21):9478-9491. PubMed ID: 31672930
[TBL] [Abstract][Full Text] [Related]
26. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
27. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
28. Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer.
Hu D; Zhou M; Zhu X
Biomed Res Int; 2019; 2019():2506843. PubMed ID: 31886185
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis.
Zhai W; Lu H; Dong S; Fang J; Yu Z
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):853-863. PubMed ID: 32556097
[TBL] [Abstract][Full Text] [Related]
30. Integrated Analysis of Three Publicly Available Gene Expression Profiles Identified Genes and Pathways Associated with Clear Cell Renal Cell Carcinoma.
Han Y; Wang L; Wang Y
Med Sci Monit; 2020 Jul; 26():e919965. PubMed ID: 32712616
[TBL] [Abstract][Full Text] [Related]
31. Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma.
Jiao F; Sun H; Yang Q; Sun H; Wang Z; Liu M; Chen J
Int J Med Sci; 2020; 17(11):1610-1624. PubMed ID: 32669964
[TBL] [Abstract][Full Text] [Related]
32. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
33. Transmembrane signaling molecules play a key role in the pathogenesis of IgA nephropathy: a weighted gene co-expression network analysis study.
Gholaminejad A; Roointan A; Gheisari Y
BMC Immunol; 2021 Dec; 22(1):73. PubMed ID: 34861820
[TBL] [Abstract][Full Text] [Related]
34. Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma.
Bai S; Wu Y; Yan Y; Shao S; Zhang J; Liu J; Hui B; Liu R; Ma H; Zhang X; Ren J
Sci Rep; 2020 Aug; 10(1):13659. PubMed ID: 32788609
[TBL] [Abstract][Full Text] [Related]
35. Integrative bioinformatics and experimental validation of hub genetic markers in acne vulgaris: Toward personalized diagnostic and therapeutic strategies.
Lin Q; Cai B; Ke R; Chen L; Ni X; Liu H; Lin X; Wang B; Shan X
J Cosmet Dermatol; 2024 May; 23(5):1777-1799. PubMed ID: 38268224
[TBL] [Abstract][Full Text] [Related]
36. Identification of potential biomarkers and candidate therapeutic drugs for clear cell renal cell carcinoma by bioinformatic analysis and reverse network pharmacology.
Meng Z; Yuan B; Yang S; Fu X; Zhang B; Xu K; Bao P; Huang Y
Medicine (Baltimore); 2023 Sep; 102(35):e34929. PubMed ID: 37657024
[TBL] [Abstract][Full Text] [Related]
37. Analysis and verification of
Yang Z; Peng B; Pan Y; Gu Y
Bioengineered; 2021 Dec; 12(2):9473-9483. PubMed ID: 34699322
[No Abstract] [Full Text] [Related]
38. Identification of differential immune cells and related diagnostic genes in patients with diabetic retinopathy.
Yuan L; Zhang L; Liu X; Li S; Zou J
Medicine (Baltimore); 2023 Sep; 102(39):e35331. PubMed ID: 37773794
[TBL] [Abstract][Full Text] [Related]
39. Establishment of Sunitinib-Resistant Xenograft Model of Renal Cell Carcinoma and the Identification of Drug-Resistant Hub Genes and Pathways.
Xie Y; Shangguan W; Chen Z; Zheng Z; Chen Y; Zhong Q; Zhang Y; Yang J; Zhu D; Xie W
Drug Des Devel Ther; 2021; 15():5061-5074. PubMed ID: 34938069
[TBL] [Abstract][Full Text] [Related]
40. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
